Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03058666 · ClinicalTrials.gov registry record · Phase 3
Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients
A Phase 3 study, sponsored by ONY.
- Completed
- Registry status
- Phase 3
- Development phase
- 477
- Enrollment target
NCT03058666 is a Phase 3 study that has completed, run by ONY. The registered enrollment target is 477 participants.
The verdict
NCT03058666, a Phase 3 study, has completed, sponsored by ONY.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 477 participants
- Enrollment target
Study Summary
Study to test the hypothesis that aerosolized Infasurf can decrease the need for intubation and instillation of liquid surfactant to the airway.
Interventions
- DRUG Aerosolized Calfactant
- DEVICE Solarys
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 477 participants |
| Start Date | 2017-03-29 |
| Est. Completion | 2018-07-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03058666
The ClinicalTrials.gov registry entry for NCT03058666 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 477 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ONY, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aerosolized Calfactant is the first listed.
NCT03058666 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03058666 about?
NCT03058666 is a clinical study titled "Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients". Study to test the hypothesis that aerosolized Infasurf can decrease the need for intubation and instillation of liquid surfactant to the airway.
What is the current status of trial NCT03058666?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 477 participants. The study started on 2017-03-29. Estimated completion is 2018-07-31.
What interventions are being tested in trial NCT03058666?
The interventions under investigation include: Aerosolized Calfactant (DRUG), Solarys (DEVICE).
Who is sponsoring clinical trial NCT03058666?
This trial is sponsored by ONY, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.